A rapid, routine microaffinity chromatographic procedure with spectrometric detection was evaluated to measure the concentration of total and free cholesterol, triglycerides, and phospholipids linked to the a-and f3-Ipre-3-lipoproteins in very small serum samples from small experimental animals and from humans. This procedure overcomes many of the limitations presented by methods involving ultracentrifugation, electrophoresis, or precipitation. Using this method, we report that in 35 adult male Mongolian gerbils (Meriones unguiculatus) fed a basal commercial diet with no cholesterol supplementation, the mean (± SD) concentration of total and free cholesterol linked to the a-Iipoprotein fraction (in mmol/L) is 2.85 ± 0.81 and 0.33 ± 0.14, respectively; phospholipids were 1.99 ± 0.41, and triglycerides were 0.64 ± 0.42. The concentration (mmol/L) of total and free cholesterol associated with the /3-/pre-3-lipoprotein fraction is 0.92 ± 0.26 and 0.22 ± 0.06, respectively; phospholipids were 0.28 ± 0.17, and triglycerides were 0.49 ± 0.31. fractions (14, 15) .
IndexIngTerms
linked to the a-and -/pre-p-LP fractions in small volumes of blood from experimental animals (rats and gerbils) during the "in-life" stage of a study. We also checked, by comparison with other methods, the specificity of this method for separating these LP fractions in animal blood.
Materials and Methods

Chemicals
All chemicals
were of the highest grades of purity available and were obtained from either Sigma Chemi- and VLDL (pre-). To assess the reproducibility of this procedure, we used commercial control sera (Isolab). Data are usually expressed as the mean ± SD. Student's t-test for paired data was used where appropriate. a-LP fraction in the three species tested showed similar elution within the same sample volumes. In contrast, the 3-/pre--LP fraction in gerbil and rat sera was eluted slightly before that present in human serum. The peak areas of the a-LP fraction in the human and gerbil samples were larger than that of the rat, whereas those of the 13-/pre-/3-LP fraction of the gerbil and rat were less than that of the human. These results indicate that, despite speciesdifferences of the a-and /3-/pre-/3-LP profiles, the method adequately separates the two LP fractions. To check this, we used other biochemical techniques.
Preparationof the LP Fractions
Electrophoresis.
To check the purity of the a-and 13-/pre-13-LP fractions obtained after microaffinity chromatographic separation of human, rat, and gerbil sera, we evaluated the electrophoretic patterns of the eluted fractions ( Figure   2, bottom panels) . No contamination between a-and j3-/pre-/3-LP fractions was observed in any sample. These three representative densitometric scans of the electrophoretic gels, for which the major peak is arbitrarily set at 100%, show a consistent major and sometimes complex (for rat serum) peak corresponding to the a-LP fraction for all species. Using the same sample volume of eluted fractions for electrophoretic analysis, we detected the $-/pre--LP fraction in human serum but no detectable electrophoretic bands corresponding to the human type f-/pre-j3-LP in (3-/pre-(3-LP eluted fractions from the rat and gerbil sera. This absence was due to the low concentrations of /3-/pre-13-LP in the whole serum of these animals (Figure 2, top panels) and to the high dilution of the sample after the affinity chromatography step. 
The repeatability of the assay was estimated by loading 10 columns with the same fresh human serum and carrying out the lipid determinations on the same day.
Results (Table 1) show that the combined precision of both column-to-column and lipid analysis (expressed as the coefficient of variation, CV) ranged between 2.3% and 4.6% for total and free cholesterol in both the a-and -LP fractions. Triglycerides analysis had a CV of -5%
for both fractions, whereas the CVs of phospholipid determinations in the a-and 13-LP fractions were 7.8% and 3.9%, respectively.
The between-day reproducibility was determined over 6 months by assaying two different daily reconstituted commercial control sera. These control sera have very different concentrations of total cholesterol as well as different LP profiles. Table 1 summarizes the results and shows that the CV for total cholesterol and phospholipids determinations ranged between 4.5% and 6.2% for both a-and f3-LP fractions. The higher CVs ments was noticeably large, but because the within-day precision of this assay was good, we suppose that this variability was due to inconsistent day-to-day performance of the triglyceride assay and to low concentrations of triglycerides.
The extent of retrieval of lipids in the column eluates was assessed by comparing the sum of these lipids in the a-and 13-LP fractions with that measured directly in whole sera having various lipid concentrations ( Table  2) 
Combined Column Separationand Lipid Measurements
One aim of our study was to reduce the sample vol- Concentration in gerbil whole serum (mmoVL) a -. between thewhole serum and the sum of the a-and -/pre-p-LP fractions in gerbils feds basal commercial diet (#{149}) or dietsupplemented with as much as 5% (by wt.) oils(0). (---- Figure 2) . The precipitation method with phosphotungstate-magnesium chloride, used to measure HDL total cholesterol and phospholipids, requires large volumes of sera, which might be unacceptable for the live phase of small-animal studies. In addition, the precipitation method for rat HDL requires higher concentrations of MgC12 than is found in commercial kits used for human HDL determinations (10). For humans only, the amount of 13-/pre- Figure   4 ; Table 2 ).
This approach offers other analytical advantages: (a) because the sum of the lipid concentrations within the a-and f3-/pre-/3-LP correlates with that found in whole serum, one does not have to measure the latter directly (Figure 4 ; we are currently studying the possibility that modification f the method might permit separation of other physiologically relevant LP fractions, e.g., the HDL isomers in the a-LP fraction, and VLDL (pre-/3) from LDL (3) in the 3-/pre-3-LP fraction.
Comparing the lipid composition of the LPs in gerbil, rat, and human sera (Figure 1; Table 2) showed that, as expected, human blood samples have more cholesterol in the 13-/pre-3-than in the a-LP fraction but that the reverse was true for samples from rats and gerbils (our results, and 14). The concentration of cholesterol in the a-LP fraction was quite high in the gerbil. These findings are similar to those observed in other studies involving similar dietary conditions (22, 23). Differences in the a-to /3-/pre-/3-LP ratios between humans and gerbils suggest that the gerbil might not reflect the LP profile seen in human LP metabolism as well as previously thought; however, this difference might also be explained by the influence of cholesterol content in the diet (19, 23) . For example, when 1 g/kg cholesterol was added to the gerbil diet (corresponding to that usually found in human diets), serum total cholesterol content increased and the cholesterol distribution in the LPs was then closer to that seen in human sera (19). Our data for total and free cholesterol (Table 2 ) are in good agreement with other workers who studied gerbils fed similar diets having no supplementary cholesterol (23). We also provide new data describing the lipid composition (phospholipids and triglycerides) of gerbil LP.
In summary, the microaffinity chromatography method coupled with lipid quantification can be used for the analysis of total and free cholesterol, phospholipids, and triglycerides in the a-and /3-/pre-j3-LP fractions in very small volumes of serum, e.g., 25 L of human, rat, or gerbil sera. Accordingly, one can rapidly and reliably measure these various lipid components in LP fractions at various times during the "in life" phase of a smallanimal study. The method offers an attractive alternative to other analytical techniques for LP fractionation and characterization.
